APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microneedle Drug Delivery Systems

Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.

Selected research

Market Outlook & Growth Opportunities

Global Microneedle Drug Delivery Systems Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchMicroneedle Drug Delivery Systems Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Microneedle Drug Delivery Systems Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Microneedle Drug Delivery Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microneedle Drug Delivery Systems Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Microneedle Drug Delivery Systems Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Microneedle drug delivery systems usually include Hollow Microneedle Technology microneedle and Dissolving Microneedles Technology microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.

In this report, we mainly study the forecast market due to there is no product on the market, most product on the research.

Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.

Read the full market overview

The classification of Microneedle Drug Delivery Systems includes Hollow Microneedle Technology, Solid Microneedle Technology and Dissolving Microneedles Technology, and the proportion of Hollow Microneedle Technology occupies the most proportions.

Microneedle Drug Delivery Systems is widely used in Drug Delivery, Vaccine Delivery and other field. The most proportion of Microneedle Drug Delivery Systems is used for vaccine delivery.

3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report provides an overview of the global Microneedle Drug Delivery Systems market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microneedle Drug Delivery Systems and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microneedle Drug Delivery Systems revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microneedle Drug Delivery Systems market.

Microneedle Drug Delivery Systems Segment by Company

KINDEVA

Zosano Pharma

Becton-Dickinson(BD)Technologies

Nanopass Technologies

Corium

Valeritas

Nitto

Microdermics

TheraJect, Inc

Vaxxas

Lohmann Therapie-Systeme AG

Microneedle Drug Delivery Systems Segment by Type

Hollow Microneedle Technology

Solid Microneedle Technology

Dissolving Microneedles Technology

Microneedle Drug Delivery Systems Segment by Application

Drug Delivery

Vaccine Delivery

Microneedle Drug Delivery Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microneedle Drug Delivery Systems status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microneedle Drug Delivery Systems key companies, revenue, market share, and recent developments.

3. To split the Microneedle Drug Delivery Systems breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microneedle Drug Delivery Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microneedle Drug Delivery Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Microneedle Drug Delivery Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microneedle Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microneedle Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microneedle Drug Delivery Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microneedle Drug Delivery Systems industry.

Chapter 3: Detailed analysis of Microneedle Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microneedle Drug Delivery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microneedle Drug Delivery Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microneedle Drug Delivery Systems Industry Trends Table 2. Microneedle Drug Delivery Systems Industry Drivers Table 3. Microneedle Drug Delivery Systems Industry Opportunities and Challenges Table 4. Microneedle Drug Delivery Systems Industry Restraints Table 5. Global Microneedle Drug Delivery Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microneedle Drug Delivery Systems Revenue Share by Company (2021-2026) Table 7. Global Microneedle Drug Delivery Systems Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microneedle Drug Delivery Systems Key Company Manufacturing Base & Headquarters Table 9. Global Microneedle Drug Delivery Systems Company, Product Type & Application Table 10. Global Microneedle Drug Delivery Systems Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microneedle Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hollow Microneedle Technology Table 15. Significant Companies of Solid Microneedle Technology Table 16. Significant Companies of Dissolving Microneedles Technology Table 17. Global Microneedle Drug Delivery Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Microneedle Drug Delivery Systems Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Microneedle Drug Delivery Systems Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Microneedle Drug Delivery Systems Sales Value Share by Type (2021-2026) Table 21. Global Microneedle Drug Delivery Systems Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Drug Delivery Table 23. Significant Companies of Vaccine Delivery Table 24. Global Microneedle Drug Delivery Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Microneedle Drug Delivery Systems Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Microneedle Drug Delivery Systems Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Microneedle Drug Delivery Systems Sales Value Share by Application (2021-2026) Table 28. Global Microneedle Drug Delivery Systems Sales Value Share by Application (2027-2032) Table 29. Global Microneedle Drug Delivery Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Microneedle Drug Delivery Systems Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Microneedle Drug Delivery Systems Sales Value Share by Region (2021-2026) Table 32. Global Microneedle Drug Delivery Systems Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Microneedle Drug Delivery Systems Sales Value Share by Region (2027-2032) Table 34. Global Microneedle Drug Delivery Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Microneedle Drug Delivery Systems Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Microneedle Drug Delivery Systems Sales Value Market Share by Country (2021-2026) Table 37. Global Microneedle Drug Delivery Systems Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Microneedle Drug Delivery Systems Sales Value Market Share by Country (2027-2032) Table 39. KINDEVA Company Information Table 40. KINDEVA Business Overview Table 41. KINDEVA Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. KINDEVA Microneedle Drug Delivery Systems Product Portfolio Table 43. KINDEVA Recent Development Table 44. Zosano Pharma Company Information Table 45. Zosano Pharma Business Overview Table 46. Zosano Pharma Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Zosano Pharma Microneedle Drug Delivery Systems Product Portfolio Table 48. Zosano Pharma Recent Development Table 49. Becton-Dickinson(BD)Technologies Company Information Table 50. Becton-Dickinson(BD)Technologies Business Overview Table 51. Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product Portfolio Table 53. Becton-Dickinson(BD)Technologies Recent Development Table 54. Nanopass Technologies Company Information Table 55. Nanopass Technologies Business Overview Table 56. Nanopass Technologies Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Nanopass Technologies Microneedle Drug Delivery Systems Product Portfolio Table 58. Nanopass Technologies Recent Development Table 59. Corium Company Information Table 60. Corium Business Overview Table 61. Corium Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Corium Microneedle Drug Delivery Systems Product Portfolio Table 63. Corium Recent Development Table 64. Valeritas Company Information Table 65. Valeritas Business Overview Table 66. Valeritas Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Valeritas Microneedle Drug Delivery Systems Product Portfolio Table 68. Valeritas Recent Development Table 69. Nitto Company Information Table 70. Nitto Business Overview Table 71. Nitto Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Nitto Microneedle Drug Delivery Systems Product Portfolio Table 73. Nitto Recent Development Table 74. Microdermics Company Information Table 75. Microdermics Business Overview Table 76. Microdermics Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Microdermics Microneedle Drug Delivery Systems Product Portfolio Table 78. Microdermics Recent Development Table 79. TheraJect, Inc Company Information Table 80. TheraJect, Inc Business Overview Table 81. TheraJect, Inc Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. TheraJect, Inc Microneedle Drug Delivery Systems Product Portfolio Table 83. TheraJect, Inc Recent Development Table 84. Vaxxas Company Information Table 85. Vaxxas Business Overview Table 86. Vaxxas Microneedle Drug Delivery Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Vaxxas Microneedle Drug Delivery Systems Product Portfolio Table 88. Vaxxas Recent Development Table 89. Lohmann Therapie-Systeme AG Company Information Table 90. Lohmann Therapie-Systeme AG Business Overview Table 91. Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Sales (), Value (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 92. Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product Portfolio Table 93. Lohmann Therapie-Systeme AG Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Microneedle Drug Delivery Systems Product Image Figure 2. Global Microneedle Drug Delivery Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microneedle Drug Delivery Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Microneedle Drug Delivery Systems Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hollow Microneedle Technology Image Figure 8. Solid Microneedle Technology Image Figure 9. Dissolving Microneedles Technology Image Figure 10. Global Microneedle Drug Delivery Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Microneedle Drug Delivery Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Microneedle Drug Delivery Systems Sales Value Share by Type (2021-2032) Figure 13. Drug Delivery Image Figure 14. Vaccine Delivery Image Figure 15. Global Microneedle Drug Delivery Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Microneedle Drug Delivery Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Microneedle Drug Delivery Systems Sales Value Share by Application (2021-2032) Figure 18. Global Microneedle Drug Delivery Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Microneedle Drug Delivery Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Microneedle Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 21. North America Microneedle Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Microneedle Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Microneedle Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Microneedle Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Microneedle Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Microneedle Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 27. South America Microneedle Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Microneedle Drug Delivery Systems Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Microneedle Drug Delivery Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Hollow Microneedle Technology
  • Solid Microneedle Technology
  • Dissolving Microneedles Technology
Applications
  • Drug Delivery
  • Vaccine Delivery
Companies covered
  • KINDEVA
  • Zosano Pharma
  • Becton-Dickinson(BD)Technologies
  • Nanopass Technologies
  • Corium
  • Valeritas
  • Nitto
  • Microdermics
  • TheraJect, Inc
  • Vaxxas
  • Lohmann Therapie-Systeme AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microneedle Drug Delivery Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microneedle Drug Delivery Systems Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microneedle Drug Delivery Systems Market Dynamics
  1. 2.1 Microneedle Drug Delivery Systems Industry Trends
  2. 2.2 Microneedle Drug Delivery Systems Industry Drivers
  3. 2.3 Microneedle Drug Delivery Systems Industry Opportunities and Challenges
  4. 2.4 Microneedle Drug Delivery Systems Industry Restraints
3 Microneedle Drug Delivery Systems Market by Company
  1. 3.1 Global Microneedle Drug Delivery Systems Company Revenue Ranking in 2025
  2. 3.2 Global Microneedle Drug Delivery Systems Revenue by Company (2021-2026)
  3. 3.3 Global Microneedle Drug Delivery Systems Company Ranking (2024-2026)
  4. 3.4 Global Microneedle Drug Delivery Systems Company Manufacturing Base and Headquarters
  5. 3.5 Global Microneedle Drug Delivery Systems Company Product Type and Application
  6. 3.6 Global Microneedle Drug Delivery Systems Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microneedle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microneedle Drug Delivery Systems Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microneedle Drug Delivery Systems Market by Type
  1. 4.1 Microneedle Drug Delivery Systems Type Introduction
  2. 4.1.1 Hollow Microneedle Technology
  3. 4.1.2 Solid Microneedle Technology
  4. 4.1.3 Dissolving Microneedles Technology
  5. 4.2 Global Microneedle Drug Delivery Systems Sales Value by Type
  6. 4.2.1 Global Microneedle Drug Delivery Systems Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Microneedle Drug Delivery Systems Sales Value by Type (2021-2032)
  8. 4.2.3 Global Microneedle Drug Delivery Systems Sales Value Share by Type (2021-2032)
5 Microneedle Drug Delivery Systems Market by Application
  1. 5.1 Microneedle Drug Delivery Systems Application Introduction
  2. 5.1.1 Drug Delivery
  3. 5.1.2 Vaccine Delivery
  4. 5.2 Global Microneedle Drug Delivery Systems Sales Value by Application
  5. 5.2.1 Global Microneedle Drug Delivery Systems Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Microneedle Drug Delivery Systems Sales Value by Application (2021-2032)
  7. 5.2.3 Global Microneedle Drug Delivery Systems Sales Value Share by Application (2021-2032)
6 Microneedle Drug Delivery Systems Regional Value Analysis
  1. 6.1 Global Microneedle Drug Delivery Systems Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microneedle Drug Delivery Systems Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microneedle Drug Delivery Systems Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microneedle Drug Delivery Systems Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microneedle Drug Delivery Systems Sales Value (2021-2032)
  7. 6.3.2 North America Microneedle Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microneedle Drug Delivery Systems Sales Value (2021-2032)
  10. 6.4.2 Europe Microneedle Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microneedle Drug Delivery Systems Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microneedle Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microneedle Drug Delivery Systems Sales Value (2021-2032)
  16. 6.6.2 South America Microneedle Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microneedle Drug Delivery Systems Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microneedle Drug Delivery Systems Sales Value Share by Country, 2025 VS 2032
7 Microneedle Drug Delivery Systems Country-level Value Analysis
  1. 7.1 Global Microneedle Drug Delivery Systems Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microneedle Drug Delivery Systems Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microneedle Drug Delivery Systems Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microneedle Drug Delivery Systems Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microneedle Drug Delivery Systems Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microneedle Drug Delivery Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microneedle Drug Delivery Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KINDEVA
  2. 8.1.1 KINDEVA Company Information
  3. 8.1.2 KINDEVA Business Overview
  4. 8.1.3 KINDEVA Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  5. 8.1.4 KINDEVA Microneedle Drug Delivery Systems Product Portfolio
  6. 8.1.5 KINDEVA Recent Developments
  7. 8.2 Zosano Pharma
  8. 8.2.1 Zosano Pharma Company Information
  9. 8.2.2 Zosano Pharma Business Overview
  10. 8.2.3 Zosano Pharma Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zosano Pharma Microneedle Drug Delivery Systems Product Portfolio
  12. 8.2.5 Zosano Pharma Recent Developments
  13. 8.3 Becton-Dickinson(BD)Technologies
  14. 8.3.1 Becton-Dickinson(BD)Technologies Company Information
  15. 8.3.2 Becton-Dickinson(BD)Technologies Business Overview
  16. 8.3.3 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Becton-Dickinson(BD)Technologies Microneedle Drug Delivery Systems Product Portfolio
  18. 8.3.5 Becton-Dickinson(BD)Technologies Recent Developments
  19. 8.4 Nanopass Technologies
  20. 8.4.1 Nanopass Technologies Company Information
  21. 8.4.2 Nanopass Technologies Business Overview
  22. 8.4.3 Nanopass Technologies Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nanopass Technologies Microneedle Drug Delivery Systems Product Portfolio
  24. 8.4.5 Nanopass Technologies Recent Developments
  25. 8.5 Corium
  26. 8.5.1 Corium Company Information
  27. 8.5.2 Corium Business Overview
  28. 8.5.3 Corium Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Corium Microneedle Drug Delivery Systems Product Portfolio
  30. 8.5.5 Corium Recent Developments
  31. 8.6 Valeritas
  32. 8.6.1 Valeritas Company Information
  33. 8.6.2 Valeritas Business Overview
  34. 8.6.3 Valeritas Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Valeritas Microneedle Drug Delivery Systems Product Portfolio
  36. 8.6.5 Valeritas Recent Developments
  37. 8.7 Nitto
  38. 8.7.1 Nitto Company Information
  39. 8.7.2 Nitto Business Overview
  40. 8.7.3 Nitto Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nitto Microneedle Drug Delivery Systems Product Portfolio
  42. 8.7.5 Nitto Recent Developments
  43. 8.8 Microdermics
  44. 8.8.1 Microdermics Company Information
  45. 8.8.2 Microdermics Business Overview
  46. 8.8.3 Microdermics Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Microdermics Microneedle Drug Delivery Systems Product Portfolio
  48. 8.8.5 Microdermics Recent Developments
  49. 8.9 TheraJect, Inc
  50. 8.9.1 TheraJect, Inc Company Information
  51. 8.9.2 TheraJect, Inc Business Overview
  52. 8.9.3 TheraJect, Inc Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  53. 8.9.4 TheraJect, Inc Microneedle Drug Delivery Systems Product Portfolio
  54. 8.9.5 TheraJect, Inc Recent Developments
  55. 8.10 Vaxxas
  56. 8.10.1 Vaxxas Company Information
  57. 8.10.2 Vaxxas Business Overview
  58. 8.10.3 Vaxxas Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vaxxas Microneedle Drug Delivery Systems Product Portfolio
  60. 8.10.5 Vaxxas Recent Developments
  61. 8.11 Lohmann Therapie-Systeme AG
  62. 8.11.1 Lohmann Therapie-Systeme AG Company Information
  63. 8.11.2 Lohmann Therapie-Systeme AG Business Overview
  64. 8.11.3 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lohmann Therapie-Systeme AG Microneedle Drug Delivery Systems Product Portfolio
  66. 8.11.5 Lohmann Therapie-Systeme AG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst